Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry

被引:26
|
作者
Weiland, Florian [1 ]
Fritz, Katarina [1 ]
Oehler, Martin K. [2 ]
Hoffmann, Peter [1 ]
机构
[1] Univ Adelaide, Adelaide Prote Ctr, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia
[2] Univ Adelaide, Res Ctr Reprod Hlth, Robinson Inst, Adelaide, SA 5005, Australia
来源
关键词
CA125; mucin; 16; mass spectrometry; ovarian cancer; antibody; false-positives; CA; 125; MONOCLONAL-ANTIBODY; ANTIGEN; CA-125; SERUM; MUCUS; QUANTIFICATION; PROTEIN; CELLS; FLUID;
D O I
10.3390/ijms13089942
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CA125 is the most widely used tumour marker in ovarian cancer with unsatisfactory sensitivity and specificity especially at early stage. It is quantified by antibody-based immunoassays; however different molecular weight isoforms have been described in the literature which have never been validated by mass spectrometry, potentially affecting the diagnostic accuracy and clinical reliability of the test. In this study, CA125 was detected by Western blot and its identity confirmed by mass spectrometry. Two-dimensional (2D) gel electrophoresis in combination with mass spectrometry revealed that positive Western blot signals up to 500 kDa are most likely false-positive interactions of M11-like and OC125-like antibodies. Fibronectin, identified as one of these false-positive interaction partners, increased the reading for CA125 in a first generation ELISA significantly (p = 0.02). The existence of low-molecular weight isoforms of CA125 is therefore questionable and is most likely reflecting cross-reactivity of the antibodies with other proteins. This would explain the conflicting reports on the molecular structure of CA125 and also the inconsistency of CA125 levels by different ELISAs. Our results are also the first steps towards a mass spectrometric assay for CA125 quantification, which would improve sensitivity and reliability.
引用
收藏
页码:9942 / 9958
页数:17
相关论文
共 50 条
  • [1] Ovarian hemangioma with elevated CA125 and ascites mimicking ovarian cancer
    Erdemoglu, E
    Kamaci, M
    Özen, S
    Sahin, HG
    Kolusari, A
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2006, 27 (02) : 195 - 196
  • [2] Ovarian thecoma with ascites and high serum levels of CA125
    Takemori, M
    Nishimura, R
    Hasegawa, K
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2000, 264 (01) : 42 - 44
  • [3] Ovarian thecoma with ascites and high serum levels of CA125
    M. Takemori
    Ryuichiro Nishimura
    Kazuo Hasegawa
    Archives of Gynecology and Obstetrics, 2000, 264 : 42 - 44
  • [4] Raised Ca125 and ascites: Is this ovarian cancer till proven otherwise?
    Birkett, Russell
    Parry-Smith, William
    Todd, Richard
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 36 (04) : 498 - 499
  • [5] CA125 in ovarian cancer
    Scholler, Nathalie
    Urban, Nicole
    BIOMARKERS IN MEDICINE, 2007, 1 (04) : 513 - 523
  • [6] Affinity-free enrichment and mass spectrometry analysis of the ovarian cancer biomarker CA125 (MUC16) from patient-derived ascites
    Schuster-Little, Naviya
    Fritz-Klaus, Roberta
    Etzel, Mark
    Patankar, Niharika
    Javeri, Saahil
    Patankar, Manish S.
    Whelan, Rebecca J.
    ANALYST, 2021, 146 (01) : 85 - 94
  • [7] Benign ovarian fibroma with ascites and high serum levels of CA125:: a case report
    Shabani, N.
    Puchner, T.
    W, Schuetze
    Jeschke, U.
    Mylonas, I
    Friese, K.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2007, 67 (05) : 532 - 532
  • [8] CA125 Immune Complexes in Ovarian Cancer Patients with Low CA125 Concentrations
    Cramer, Daniel W.
    O'Rourke, Dennis J.
    Vitonis, Allison F.
    Matulonis, Ursula A.
    DiJohn-son, Daniel A.
    Sluss, Patrick M.
    Crum, Christopher P.
    Liu, Brian C. -S.
    CLINICAL CHEMISTRY, 2010, 56 (12) : 1889 - 1892
  • [9] Ovarian cancer: the duplicity of CA125 measurement
    Karam, Amer K.
    Karlan, Beth Y.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (06) : 335 - 339
  • [10] Ovarian cancer: the duplicity of CA125 measurement
    Amer K. Karam
    Beth Y. Karlan
    Nature Reviews Clinical Oncology, 2010, 7 : 335 - 339